tradingkey.logo
tradingkey.logo
検索

Simulations Plus Inc

SLP
ウォッチリストに追加
18.390USD
+0.040+0.22%
終値 07/02, 13:00ET15分遅れの株価
370.50M時価総額
損失額直近12ヶ月PER

詳細情報 Simulations Plus Inc 企業名

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Simulations Plus Incの企業情報

企業コードSLP
会社名Simulations Plus Inc
上場日Jun 18, 1997
最高経営責任者「CEO」O'Connor (Shawn M)
従業員数212
証券種類Ordinary Share
決算期末Jun 18
本社所在地800 Park Offices Drive, Suite 401
都市RESEARCH TRIANGLE PARK
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号27709
電話番号16617237723
ウェブサイトhttps://www.simulations-plus.com/
企業コードSLP
上場日Jun 18, 1997
最高経営責任者「CEO」O'Connor (Shawn M)

Simulations Plus Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--
Ms. Lisa Fortuna
Ms. Lisa Fortuna
Investor Relations
Investor Relations
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--

よくある質問

Simulations Plus Incの上位5名の株主は誰ですか?

Simulations Plus Incの上位5名の株主は以下のとおりです。Dr. Hon. Walter S. Woltosz

Simulations Plus Inc(SLP)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Simulations Plus Incの株式を保有している機関は432社あり、保有株式の総市場価値は約17.68Mで、全体の87.48%を占めています。2025Q4と比較して、機関の持ち株は-4627215.00増加しています。

Simulations Plus Incの最大の収益源は何ですか?

2026Q1において、Consulting services部門がSimulations Plus Incにとって最大の収益を生み出しており、その金額は9.54Mで、全収益の51.78%を占めています。